An Assessment of the Effects of Serotonin 6 (5-HT6) Receptor Antagonists in Rodent Models of Learning

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 2, 2003, Pages 682-691

  Lindner, Mark D ^a   Hodges Jr , Donald B ^a   Hogan, John B ^a   Orie, Anitra F ^a   Corsa, Jason A ^a   Barten, Donna M ^a   Polson, Craig ^a   Robertson, Barbara J ^a   Guss, Valerie L ^a   Gillman, Kevin W ^a   Starrett Jr , John E ^a   Gribkoff, Valentin K ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 5 CHLORO N (4 METHOXY 3 PIPERAZIN 1 YLPHENYL) 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; CLOZAPINE; METITEPINE; PHYSOSTIGMINE; SCOPOLAMINE; SEROTONIN; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FEAR; HUMAN; IN VIVO STUDY; LEARNING; MALE; MASTICATION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SCHIZOPHRENIA; STRETCHING; YAWNING;

ANIMALS; BINDING SITES; HUMANS; LEARNING; MASTICATION; MICE; MODELS, ANIMAL; PYRIMIDINES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SULFONAMIDES; THIOPHENES; YAWNING;

EID: 0142241281     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.056002     Document Type: Article

References (39)

1. Andrews JS, Jansen JHM, Linders S, Princen A, and Broekkamp CLE (1995) Performance of four different rat strains in the autoshaping, two-object discrimination and swim maze tests of learning and memory. Physiol Behav 57:785-790.
2. Bentley JC, Bourson A, Boess FG, Fone KC, Marsden CA, Petit N, and Sleight AJ (1999) Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol 126:1537-1542.
3. Boess FG, Monsma FJ Jr, Meyer V, Zwingelstein C, and Sleight AJ (1997) Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor. Mol Pharmacol 52:515-523.
4. Boess FG, Monsma FJ Jr, and Sleight AJ (1998) Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor. J Neurochem 71:2169-2177.
5. Bos M, Sleight AJ, Godel T, Martin JR, Riemer C, and Stadler H (2001) 5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides. Eur J Med Chem 36:165-178.
6. Bourson A, Boess FG, Bos M, and Sleight AJ (1998) Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br J Pharmacol 125:1562-1566.
7. Bourson A, Borroni E, Austin RH, Monsma FJ Jr, and Sleight AJ (1995) Determination of the role of the 5-HT(6) receptor in the rat brain: a study using antisense oligonucleotides. J Pharmacol Exp Ther 274:173-180.
8. Daly DA and Moghaddam B (1993) Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats. Neurosci Lett 152:61-64.
9. Dawson LA, Nguyen HQ, and Li P (2000) In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130:23-26.
10. Dawson LA, Nguyen HQ, and Li P (2001) The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25:662-668.
11. East SZ, Burnet PW, Leslie RA, Roberts JC, and Harrison PJ (2002) 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585. Synapse 45:191-199.
12. Frederick JA and Meador-Woodruff JH (1999) Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain. Schizophr Res 38:7-12.
13. Kohen R, Fashingbauer LA, Heidmann DE, Guthrie CR, and Hamblin MW (2001) Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop. Brain Res Mol Brain Res 90:110-117.
14. Martin GR, Eglen RM, Hamblin MW, Hoyer D, and Yocca F (1998) The structure and signalling properties of 5-HT receptors: an endless diversity? Trends Pharmacol Sci 19:2-4.
15. Masellis M, Basile VS, Meltzer HY, Lieberman JA, Sevy S, Goldman DA, Hamblin MW, Macciardi FM, and Kennedy JL (2001) Lack of association between the T→C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr Res 47:49-58.
16. Meltzer HY and McGurk SR (1999) The effects of clozapine, risperidone and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255.
17. Meneses A (2001) Effects of the 5-HT(6) receptor antagonist Ro 04-6790 on learning consolidation. Behav Brain Res 118:107-110.
18. Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, and Sibley DR (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:320-327.
19. Ohmori O, Shinkai T, Hori H, and Nakamura J (2001) Novel polymorphism in the 5′-upstream region of the human 5-HT6 receptor gene and schizophrenia. Neurosci Lett 310:17-20.
20. Orlacchio A, Kawarai T, Paciotti E, Stefani A, Orlacchio A, Sorbi S, George-Hyslop PH, and Bernardi G (2002) Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease. Neurosci Lett 325:13-16.
21. Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, and Tollefson GD (2000) Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for Research in Schizophrenia. Arch Gen Psychiatry 57:249-258.
22. Reavill C and Rogers DC (2001) The therapeutic potential of 5-HT6 receptor antagonists. Curr Opin Investig Drugs 2:104-109.
23. Rogers DC and Hagan JJ (2001) 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology 158:114-119.
24. Routledge C (1999) Proceedings of the British Pharmacological Society Meeting, joint meeting with the Portuguese Society of Pharmacology. 8-9 April 1999. Abstracts; 21P.
25. Routledge C, Bromidge SM, Moss SF, Price GW, Hirst W, Newman H, Riley G, Gager T, Stean T, Upton N, et al. (2000) Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist. Br J Pharmacol 130:1606-1612.
26. Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R, and Schwartz JC (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193:268-276.
27. Russell MG and Dias R (2002) Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions. Curr Top Med Chem 2:643-654.
28. Sebben M, Ansanay H, Bockaert J, and Dumuis A (1994) 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture. Neuroreport 5:2553-2557.
29. Shinkai T, Ohmori O, Kojima H, Terao T, Suzuki T, and Abe K (1999) Association study of the 5-HT6 receptor gene in schizophrenia. Am J Med Genet 88:120-122.
30. Shirazi-Southall S, Rodriguez DE, and Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583-594.
31. Sleight AJ, Boess FG, Bos M, Levet-Trafit B, Riemer C, and Bourson A (1998) Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors. Br J Pharmacol 124:556-562.
32. 6 expression in the rat: functional studies using antisense oligonucleotides. Behav Brain Res 73:245-248.
33. Stean TO, Hirst WD, Thomas DR, Price GW, Rogers D, Riley G, Bromidge SM, Serafinowska HT, Smith DR, Bartlett S, et al. (2002) Pharmacological profile of SB-357134: a potent, selective, brain penetrant and orally active 5-HT(6) receptor antagonist. Pharmacol Biochem Behav 71:645-654.
34. Thome J, Retz W, Baader M, Pesold B, Hu M, Cowen M, Durany N, Adler G, Henn FA, and Rosler M (2001) Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease. J Neural Transm 108:1175-1180.
35. Tsai SJ, Chiu HJ, Wang YC, and Hong CJ (1999a) Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive behavior. Neurosci Lett 271:135-137.
36. Tsai SJ, Liu HC, Liu TY, Wang YC, and Hong CJ (1999b) Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease. Neurosci Lett 276:138-139.
37. Vogt IR, Shimron-Abarbanell D, Neidt H, Erdmann J, Cichon S, Schulze TG, Muller DJ, Maier W, Albus M, Borrmann-Hassenbach M, et al. (2000) Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 96:217-221.
38. Woolley ML, Bentley JC, Sleight AJ, Marsden CA, and Fone KC (2001) A role for 5-HT(6) receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41:210-219.
39. Yoshioka M, Matsumoto M, Togashi H, Mori K, and Saito H (1998) Central distribution and function of 5-HT6 receptor subtype in the rat brain. Life Sci 62:1473-1477.